Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients

NCT07932509 is registered in ClinicalTrials.gov with MTI University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07932509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients
Lead sponsor
MTI University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
December 5, 2026
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • Targeted Tracheal Kinesio Taping ExperimentalTracheal Kinesio Taping

    Participants randomized to the experimental group will receive targeted tracheal Kinesio taping as an adjunct to their daily pulmonary rehabilitation. A certified, KT-trained physical therapist will perform all applications using 5-cm wide, hypoallergenic, 100% cotton elastic tape (Kinesio® Tex Gold™). Before application, the skin surrounding the tracheostoma will be meticulously cleaned, degreased, and dried. Taping will be executed with the patient positioned in a comfortable, neutral cervical spine posture.

  • Control Active comparatorControl

    standardized daily chest physiotherapy protocol tailored for burn critical care. This encompasses early progressive mobility and ambulation, targeted diaphragmatic breathing exercises, active-assisted or manually assisted coughing, oropharyngeal secretion suctioning, and mandatory compliance with the institution's progressive tracheostomy weaning pathway

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Peak Cough Flow (PCF)expressed in Liters per minute, L/min at base line and 2 weeks

    Cough efficacy will be objectively measured using a calibrated, portable digital peak flow meter connected via an airtight respiratory adapter to the patient's fenestrated tracheostomy tube (with the cuff completely deflated and the proximal opening securely capped)

Lead sponsor's other trials

MTI University, most recent start first.

Similar trials

Same condition (Burns) and phase, most recent start first.